Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006259 · ClinicalTrials.gov registry record · Phase 2
Stereotactic Radiation Therapy in Treating Patients With Brain Metastases
A Phase 2 study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT00006259 is a Phase 2 study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 10 participants.
The verdict
NCT00006259, a Phase 2 study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
RATIONALE: Stereotactic radiation therapy may be able to deliver x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: Phase II trial to study the effectiveness of stereotactic radiation therapy in treating patients who have brain metastases.
Interventions
- RADIATION stereotactic radiosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2000-01 |
| Est. Completion | 2005-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006259
The ClinicalTrials.gov registry entry for NCT00006259 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which stereotactic radiosurgery is the first listed.
NCT00006259 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006259 about?
NCT00006259 is a clinical study titled "Stereotactic Radiation Therapy in Treating Patients With Brain Metastases". RATIONALE: Stereotactic radiation therapy may be able to deliver x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: Phase II trial to study the effectiveness of stereotactic radiation therapy in treating patients who have brain metastases.
What is the current status of trial NCT00006259?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2000-01. Estimated completion is 2005-02.
What interventions are being tested in trial NCT00006259?
The interventions under investigation include: stereotactic radiosurgery (RADIATION).
Who is sponsoring clinical trial NCT00006259?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.